Pirenoxine (International)

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0001043-21-6

Chemical Formula

C16-H8-N2-O5

Molecular Weight

308

Therapeutic Category

Cataract treatment

Chemical Name

5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo-

Foreign Names

• Pirenoxinum (Latin)
• Pirenoxin (German)
• Pirénoxine (French)
• Pirenoxina (Spanish)

Generic Names

• Pirenoxine (OS: JAN)
• Pirénoxine (OS: DCF)
• Pirfenoxone (IS)
• Pirenoxine (PH: JP XVII)

Brand Names

• Catalin
  Senju, China; Takeda, Egypt
• Catalin 0.005%
  Senju Seiyaku, Japan
• Catalin K 0.005%
  Senju Seiyaku, Japan
• Clarvisan
  Allergan, Italy; Lusomedicamenta, Portugal
• Kary Uni
  Ferron/Santen, Indonesia; Santen, Philippines; Santen, Thailand; Santen, Taiwan; Santen Pharmaceutical Asia, Singapore; Santen Pharmaceutical China, China
• Kary Uni 0.005%
  Santen Pharmaceutical, Japan
• Pirenoxine 0.005%
  Nitto Medic, Japan
• Pirenoxine Nitto Medic
  Nitto, Taiwan
• Catalin
  Allergan, India; Helix, Pakistan; PharmaHeads, Poland; Takeda, Hong Kong
• Catalin [+ Taurine]
  Takeda, Kuwait
• Clarvisol
  Allergan, Brazil
• Kary Uni
  Santen, Hong Kong
• Pirenoxine Sodium - KeRui Pharm
  Kerui Pharmaceutical, China
• Pirfalin
  Farmigea, Italy; Farmigea, Malta

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer